Commenting on the 2025 fiscal year, Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), stated, "In an extremely volatile environment, Vetoquinol has once again this year demonstrated the ...

LURE, France, April 25, 2025--(BUSINESS WIRE)--Regulatory News: On 24 April 2025, Vetoquinol (Paris:VETO) filed its 2024 Universal Registration Document with the Autorité des Marchés Financiers (AMF) ...

France-based Vetoquinol might not have quite the name recognition as its rivals in animal health, but it has been pursuing an aggressive growth strategy over the past few years that has kept it at No.

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis) Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a ...

For over 90 years, the company has been a key player in animal health. Today, it is one of the world's top 10 veterinary pharmaceutical companies. Since its creation in 1933, Vetoquinol has worked ...

PHOVIA® is a system from Vetoquinol that seeks to alleviate the limitations of the current standard of care through the use of Fluorescent Light Energy (FLE). LAVALTRIE — Vetoquinol Canada announces ...